Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (UNAUDITED)

v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (UNAUDITED) - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Subscriptions Receivable
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2018   3,793,000 (122,000)        
Beginning balance at Dec. 31, 2018 $ (226,335) $ 10 $ (30,659) $ 814,488 $ (597) $ (1,009,458) $ (119)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Restricted stock units vested and distributed, net of tax (in shares)   45,000          
Restricted stock units vested and distributed, net of tax (117)     (117)      
Stock-based compensation 2,389     2,389      
Net loss (37,609)         (37,609)  
Tax effect relating to the beneficial conversion feature of Second Lien Notes (2,688)     (2,688)      
Unrealized foreign currency translation adjustments 233           233
Ending balance (in shares) at Mar. 31, 2019   3,838,000 (122,000)        
Ending balance at Mar. 31, 2019 $ (264,127) $ 10 $ (30,659) 814,072 (597) (1,047,067) 114
Beginning balance (in shares) at Dec. 31, 2019 3,715,775 3,838,000 (122,000)        
Beginning balance at Dec. 31, 2019 $ (375,154) $ 10 $ (30,659) 818,961 (597) (1,162,901) 32
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Restricted stock units vested and distributed, net of tax (in shares)   29,000          
Restricted stock units vested and distributed, net of tax (61)     (61)      
Stock-based compensation 1,339     1,339      
Net loss (80,925)         (80,925)  
Unrealized foreign currency translation adjustments $ 237           237
Ending balance (in shares) at Mar. 31, 2020 3,867,043 3,867,000 (122,000)        
Ending balance at Mar. 31, 2020 $ (455,851) $ 10 $ (30,659) $ 820,239 $ (597) $ (1,245,113) $ 269